Inventor
ASHKENAZI AVI
US28 patents
⚠️ This page may combine multiple inventors who share the name “ASHKENAZI AVI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
25 patentsUS6635468B2Oct 21, 2003
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC92 citations99
US6838554B2Jan 4, 2005
Nucleic acids encoding proteins that stimulate the proliferation of t-lymphocytes
GENENTECH INC33 citations96
US6410708B1Jun 25, 2002
Nucleic acids encoding A-33 related antigen polypeptides
GENENTECH INC71 citations96
US8710189B2Apr 29, 2014
Anti-FGFR3 antibodies and methods using same
GENENTECH INC12 citations92
US7211400B2May 1, 2007
Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
GENENTECH INC26 citations92
US6974689B1Dec 13, 2005
Nucleic acid encoding PRO211 polypeptides
GENENTECH INC27 citations92
US6723535B2Apr 20, 2004
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC14 citations92
US8007798B2Aug 30, 2011
Treatment of complement-associated disorders
GENENTECH INC29 citations91
US7419663B2Sep 2, 2008
Treatment of complement-associated disorders
GENENTECH INC33 citations91
US7192589B2Mar 20, 2007
Treatment of inflammatory disorders with STIgMA immunoadhesins
GENENTECH INC36 citations91
US10000571B2Jun 19, 2018
Anti-FGFR3 antibodies and methods using same
GENENTECH INC6 citations84
US9499623B2Nov 22, 2016
Anti-FGFR3 antibodies and methods using same
GENENTECH INC6 citations84
US9161977B2Oct 20, 2015
Anti-FGFR3 antibodies and methods using same
GENENTECH INC4 citations84
US6664376B2Dec 16, 2003
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC9 citations82
US7799899B2Sep 21, 2010
Compositions and methods relating to STOP-1
GENENTECH INC14 citations78
US11401333B2Aug 2, 2022
Anti-FGFR3 antibodies and methods using same
GENENTECH INC1 citations73
US10287356B2May 14, 2019
Anti-FGFR3 antibodies and methods using same
GENENTECH INC1 citations73
US9925240B2Mar 27, 2018
Methods of treating and preventing cancer drug resistance
GENENTECH INC2 citations69
US9358250B2Jun 7, 2016
Methods of using SCD1 antagonists
GENENTECH INC3 citations66
US7741056B2Jun 22, 2010
Use of A33 antigens and JAM-IT
GENENTECH INC3 citations62
US7208308B2Apr 24, 2007
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC0 citations62
US7198917B2Apr 3, 2007
Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
GENENTECH INC0 citations52
US7115713B2Oct 3, 2006
Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
GENENTECH INC0 citations52
US10968203B2Apr 6, 2021
Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating IRE1-related diseases and disorders
GENENTECH INC0 citations50
US10208120B2Feb 19, 2019
Anti-FGFR2/3 antibodies and methods using same
GENENTECH INC0 citations40